O-09: DURABLE ENGRAFTMENT AFTER PHARMACOLOGICAL PRE-TRANSPLANT IMMUNOSUPPRESSION FOLLOWED BY REDUCED-TOXICITY MYELOABLATIVE HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN HIGHLY HLA-IMMUNIZED ADULTS WITH SICKLE CELL DISEASE

Detalles Bibliográficos
Autores principales: S., FÜRST, E., BERNIT, A., GRANATA, F., LEGRAND, S., HARBI, R., DEVILLIER, V., MAISANO, B., BOUCHACOURT, T., PAGLIARDINI, D., MOKART, C., LEMARIÉ, B., CALMELS, C., PICARD, A., BASIRE, C., CHABANNON, B., ANDERSSON, D., BLAISE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Oral Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426781/
http://dx.doi.org/10.1097/01.HS9.0000872844.05995.69
_version_ 1784778754744123392
author S., FÜRST
E., BERNIT
A., GRANATA
F., LEGRAND
S., HARBI
R., DEVILLIER
V., MAISANO
B., BOUCHACOURT
T., PAGLIARDINI
D., MOKART
C., LEMARIÉ
B., CALMELS
C., PICARD
A., BASIRE
C., CHABANNON
B., ANDERSSON
D., BLAISE
author_facet S., FÜRST
E., BERNIT
A., GRANATA
F., LEGRAND
S., HARBI
R., DEVILLIER
V., MAISANO
B., BOUCHACOURT
T., PAGLIARDINI
D., MOKART
C., LEMARIÉ
B., CALMELS
C., PICARD
A., BASIRE
C., CHABANNON
B., ANDERSSON
D., BLAISE
author_sort S., FÜRST
collection PubMed
description
format Online
Article
Text
id pubmed-9426781
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94267812022-08-31 O-09: DURABLE ENGRAFTMENT AFTER PHARMACOLOGICAL PRE-TRANSPLANT IMMUNOSUPPRESSION FOLLOWED BY REDUCED-TOXICITY MYELOABLATIVE HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN HIGHLY HLA-IMMUNIZED ADULTS WITH SICKLE CELL DISEASE S., FÜRST E., BERNIT A., GRANATA F., LEGRAND S., HARBI R., DEVILLIER V., MAISANO B., BOUCHACOURT T., PAGLIARDINI D., MOKART C., LEMARIÉ B., CALMELS C., PICARD A., BASIRE C., CHABANNON B., ANDERSSON D., BLAISE Hemasphere Oral Presentations Lippincott Williams & Wilkins 2022-08-16 /pmc/articles/PMC9426781/ http://dx.doi.org/10.1097/01.HS9.0000872844.05995.69 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Presentations
S., FÜRST
E., BERNIT
A., GRANATA
F., LEGRAND
S., HARBI
R., DEVILLIER
V., MAISANO
B., BOUCHACOURT
T., PAGLIARDINI
D., MOKART
C., LEMARIÉ
B., CALMELS
C., PICARD
A., BASIRE
C., CHABANNON
B., ANDERSSON
D., BLAISE
O-09: DURABLE ENGRAFTMENT AFTER PHARMACOLOGICAL PRE-TRANSPLANT IMMUNOSUPPRESSION FOLLOWED BY REDUCED-TOXICITY MYELOABLATIVE HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN HIGHLY HLA-IMMUNIZED ADULTS WITH SICKLE CELL DISEASE
title O-09: DURABLE ENGRAFTMENT AFTER PHARMACOLOGICAL PRE-TRANSPLANT IMMUNOSUPPRESSION FOLLOWED BY REDUCED-TOXICITY MYELOABLATIVE HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN HIGHLY HLA-IMMUNIZED ADULTS WITH SICKLE CELL DISEASE
title_full O-09: DURABLE ENGRAFTMENT AFTER PHARMACOLOGICAL PRE-TRANSPLANT IMMUNOSUPPRESSION FOLLOWED BY REDUCED-TOXICITY MYELOABLATIVE HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN HIGHLY HLA-IMMUNIZED ADULTS WITH SICKLE CELL DISEASE
title_fullStr O-09: DURABLE ENGRAFTMENT AFTER PHARMACOLOGICAL PRE-TRANSPLANT IMMUNOSUPPRESSION FOLLOWED BY REDUCED-TOXICITY MYELOABLATIVE HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN HIGHLY HLA-IMMUNIZED ADULTS WITH SICKLE CELL DISEASE
title_full_unstemmed O-09: DURABLE ENGRAFTMENT AFTER PHARMACOLOGICAL PRE-TRANSPLANT IMMUNOSUPPRESSION FOLLOWED BY REDUCED-TOXICITY MYELOABLATIVE HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN HIGHLY HLA-IMMUNIZED ADULTS WITH SICKLE CELL DISEASE
title_short O-09: DURABLE ENGRAFTMENT AFTER PHARMACOLOGICAL PRE-TRANSPLANT IMMUNOSUPPRESSION FOLLOWED BY REDUCED-TOXICITY MYELOABLATIVE HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN HIGHLY HLA-IMMUNIZED ADULTS WITH SICKLE CELL DISEASE
title_sort o-09: durable engraftment after pharmacological pre-transplant immunosuppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly hla-immunized adults with sickle cell disease
topic Oral Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426781/
http://dx.doi.org/10.1097/01.HS9.0000872844.05995.69
work_keys_str_mv AT sfurst o09durableengraftmentafterpharmacologicalpretransplantimmunosuppressionfollowedbyreducedtoxicitymyeloablativehaploidenticalstemcelltransplantationinhighlyhlaimmunizedadultswithsicklecelldisease
AT ebernit o09durableengraftmentafterpharmacologicalpretransplantimmunosuppressionfollowedbyreducedtoxicitymyeloablativehaploidenticalstemcelltransplantationinhighlyhlaimmunizedadultswithsicklecelldisease
AT agranata o09durableengraftmentafterpharmacologicalpretransplantimmunosuppressionfollowedbyreducedtoxicitymyeloablativehaploidenticalstemcelltransplantationinhighlyhlaimmunizedadultswithsicklecelldisease
AT flegrand o09durableengraftmentafterpharmacologicalpretransplantimmunosuppressionfollowedbyreducedtoxicitymyeloablativehaploidenticalstemcelltransplantationinhighlyhlaimmunizedadultswithsicklecelldisease
AT sharbi o09durableengraftmentafterpharmacologicalpretransplantimmunosuppressionfollowedbyreducedtoxicitymyeloablativehaploidenticalstemcelltransplantationinhighlyhlaimmunizedadultswithsicklecelldisease
AT rdevillier o09durableengraftmentafterpharmacologicalpretransplantimmunosuppressionfollowedbyreducedtoxicitymyeloablativehaploidenticalstemcelltransplantationinhighlyhlaimmunizedadultswithsicklecelldisease
AT vmaisano o09durableengraftmentafterpharmacologicalpretransplantimmunosuppressionfollowedbyreducedtoxicitymyeloablativehaploidenticalstemcelltransplantationinhighlyhlaimmunizedadultswithsicklecelldisease
AT bbouchacourt o09durableengraftmentafterpharmacologicalpretransplantimmunosuppressionfollowedbyreducedtoxicitymyeloablativehaploidenticalstemcelltransplantationinhighlyhlaimmunizedadultswithsicklecelldisease
AT tpagliardini o09durableengraftmentafterpharmacologicalpretransplantimmunosuppressionfollowedbyreducedtoxicitymyeloablativehaploidenticalstemcelltransplantationinhighlyhlaimmunizedadultswithsicklecelldisease
AT dmokart o09durableengraftmentafterpharmacologicalpretransplantimmunosuppressionfollowedbyreducedtoxicitymyeloablativehaploidenticalstemcelltransplantationinhighlyhlaimmunizedadultswithsicklecelldisease
AT clemarie o09durableengraftmentafterpharmacologicalpretransplantimmunosuppressionfollowedbyreducedtoxicitymyeloablativehaploidenticalstemcelltransplantationinhighlyhlaimmunizedadultswithsicklecelldisease
AT bcalmels o09durableengraftmentafterpharmacologicalpretransplantimmunosuppressionfollowedbyreducedtoxicitymyeloablativehaploidenticalstemcelltransplantationinhighlyhlaimmunizedadultswithsicklecelldisease
AT cpicard o09durableengraftmentafterpharmacologicalpretransplantimmunosuppressionfollowedbyreducedtoxicitymyeloablativehaploidenticalstemcelltransplantationinhighlyhlaimmunizedadultswithsicklecelldisease
AT abasire o09durableengraftmentafterpharmacologicalpretransplantimmunosuppressionfollowedbyreducedtoxicitymyeloablativehaploidenticalstemcelltransplantationinhighlyhlaimmunizedadultswithsicklecelldisease
AT cchabannon o09durableengraftmentafterpharmacologicalpretransplantimmunosuppressionfollowedbyreducedtoxicitymyeloablativehaploidenticalstemcelltransplantationinhighlyhlaimmunizedadultswithsicklecelldisease
AT bandersson o09durableengraftmentafterpharmacologicalpretransplantimmunosuppressionfollowedbyreducedtoxicitymyeloablativehaploidenticalstemcelltransplantationinhighlyhlaimmunizedadultswithsicklecelldisease
AT dblaise o09durableengraftmentafterpharmacologicalpretransplantimmunosuppressionfollowedbyreducedtoxicitymyeloablativehaploidenticalstemcelltransplantationinhighlyhlaimmunizedadultswithsicklecelldisease

Ejemplares similares